ORDSPONO
"ORDSPONO" is a word mark owned by Regeneron Pharmaceuticals, Inc., filed at the EUIPO on September 21, 2022. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since January 30, 2023
- Filed
- September 21, 2022
- Registered
- January 27, 2023
- Expires
- September 21, 2032
- Application no.
- 018764849
- Registration no.
- 018764849
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 1 class
Who owns ORDSPONO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Regeneron Pharmaceuticals, Inc.
Representative
Noerr Alicante IP, S.L.
Noerr Alicante IP, S.L
What the mark covers
The products and services ORDSPONO is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of pain
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2023/019 Section B.1
- Bulletin 2022/199 Section A.1
About ORDSPONO
Who owns the trademark "ORDSPONO"?
The EUIPO trademark "ORDSPONO" (application 018764849) is owned by Regeneron Pharmaceuticals, Inc.
What is the status of "ORDSPONO"?
Its status at the EUIPO is: registered.
When was "ORDSPONO" registered?
It was registered on January 27, 2023 and is due to expire on September 21, 2032.
Get this data via the API
Everything on this page comes from the Signa API. Pull ORDSPONO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d479e-a504-7650-b11e-fd7dc8871338
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d479e-a504-7650-b11e-fd7dc8871338",
"object": "trademark",
"mark_text": "ORDSPONO",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "018764849",
"filing_date": "2022-09-21",
"nice_classes": [
5
],
"owners": [
{
"name": "Regeneron Pharmaceuticals, Inc.",
"entity_id": "ent_019f7564-a0e8-7575-a3fd-12ec6e80fa07"
}
]
}